These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28093855)

  • 1. Typical and atypical appearance of early-onset Alzheimer's disease: A clinical, neuroimaging and neuropathological study.
    Kawakatsu S; Kobayashi R; Hayashi H
    Neuropathology; 2017 Apr; 37(2):150-173. PubMed ID: 28093855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
    Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
    J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological heterogeneity of Alzheimer's disease with pure Alzheimer's disease pathology: Cases associated with dementia with Lewy bodies, very early-onset dementia, and primary progressive aphasia.
    Kawakatsu S; Kobayashi R; Hayashi H; Morioka D; Utsunomiya A; Kabasawa T; Ohe R; Otani K
    Neuropathology; 2021 Dec; 41(6):427-449. PubMed ID: 34816507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
    Thal DR; Attems J; Ewers M
    J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.
    Gefen T; Gasho K; Rademaker A; Lalehzari M; Weintraub S; Rogalski E; Wieneke C; Bigio E; Geula C; Mesulam MM
    Brain; 2012 May; 135(Pt 5):1554-65. PubMed ID: 22522938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.
    Ohm DT; Fought AJ; Rademaker A; Kim G; Sridhar J; Coventry C; Gefen T; Weintraub S; Bigio E; Mesulam MM; Rogalski E; Geula C
    Brain Pathol; 2020 Mar; 30(2):332-344. PubMed ID: 31446630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia After Moderate-Severe Traumatic Brain Injury: Coexistence of Multiple Proteinopathies.
    Kenney K; Iacono D; Edlow BL; Katz DI; Diaz-Arrastia R; Dams-O'Connor K; Daneshvar DH; Stevens A; Moreau AL; Tirrell LS; Varjabedian A; Yendiki A; van der Kouwe A; Mareyam A; McNab JA; Gordon WA; Fischl B; McKee AC; Perl DP
    J Neuropathol Exp Neurol; 2018 Jan; 77(1):50-63. PubMed ID: 29155947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.
    Whitwell JL; Kantarci K; Weigand SD; Lundt ES; Gunter JL; Duffy JR; Strand EA; Machulda MM; Spychalla AJ; Drubach DA; Petersen RC; Lowe VJ; Jack CR; Josephs KA
    J Alzheimers Dis; 2015; 45(4):1109-17. PubMed ID: 25649655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
    Leyton CE; Villemagne VL; Savage S; Pike KE; Ballard KJ; Piguet O; Burrell JR; Rowe CC; Hodges JR
    Brain; 2011 Oct; 134(Pt 10):3030-43. PubMed ID: 21908392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration.
    Okazaki K; Fu YJ; Nishihira Y; Endo M; Fukushima T; Ikeuchi T; Okamoto K; Onodera O; Nishizawa M; Takahashi H
    Neuropathology; 2010 Apr; 30(2):140-8. PubMed ID: 19780981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
    Beach TG; Sue LI; Walker DG; Sabbagh MN; Serrano G; Dugger BN; Mariner M; Yantos K; Henry-Watson J; Chiarolanza G; Hidalgo JA; Souders L
    J Alzheimers Dis; 2012; 28(4):869-76. PubMed ID: 22112552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of pathology in frontal variant Alzheimer's disease.
    Blennerhassett R; Lillo P; Halliday GM; Hodges JR; Kril JJ
    J Alzheimers Dis; 2014; 39(1):63-70. PubMed ID: 24121962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gerstmann-Sträussler syndrome--a variant type: amyloid plaques and Alzheimer's neurofibrillary tangles in cerebral cortex.
    Amano N; Yagishita S; Yokoi S; Itoh Y; Kinoshita J; Mizutani T; Matsuishi T
    Acta Neuropathol; 1992; 84(1):15-23. PubMed ID: 1502879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
    Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
    Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
    Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
    Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.